Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Low serum ferritin is linked to hair loss in women.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Combining minoxidil with other treatments like finasteride or PRP improves hair growth and satisfaction more than using minoxidil alone.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Low vitamin D3 is not linked to different levels of thyroid hormones in people with autoimmune thyroid disease.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Sex hormones, especially androgens, play a key role in causing acne.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Testosterone affects vascular cells directly without converting to estradiol.

Prenatal pesticide exposure may cause earlier breast development in girls.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.